Abridge CEO Shiv Rao on raising $300 million, a prospective IPO, and the future of healthcare
Briefly

Shiv Rao, CEO and cofounder of Abridge, emphasizes the importance of growing old with patients and partners through his dual roles as a cardiologist and healthcare entrepreneur. Abridge, which specializes in medical transcription and recently raised $300 million in Series E funding, is experiencing rapid growth, now valued at $5.3 billion and present in over 150 health systems. With competition in the healthcare AI space, Rao prioritizes preserving options for the company's future, whether through an IPO or remaining private longer.
"You grow old with your patients as a clinician, and that's such an incredible privilege that doctors and nurses get," said Rao.
"In this new life, I think we're growing old with all of our partners. It's a different altitude. As we grow old with Kaiser, we're growing old with 26,000 clinicians at Kaiser, and the several millions of patients that those clinicians serve."
"At this point in time, the amount of capital that we've got in the bank, the amount that we're going to invest into R&D, I think we need to preserve all the optionality in the world."
Read at Fortune
[
|
]